Citius Pharmaceuticals logo
Citius Pharmaceuticals CTXR
$ 0.51 4.08%
report update icon

Quarterly report 2026-Q2
added 05-15-2026

Citius Pharmaceuticals Retained Earnings | CTXR

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Citius Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
-239 M -201 M -162 M -130 M -96 M -70.6 M -55.8 M -40.3 M -27.7 M -17.3 M -9.04 M -6.14 M -95.2 K -63.8 K -41.8 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-41.8 K -239 M -70.4 M

Quarterly Retained Earnings Citius Pharmaceuticals

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-268 M -247 M -247 M -239 M -231 M -222 M -211 M -201 M -191 M -180 M -171 M -162 M -152 M -144 M -133 M -130 M -122 M -113 M -105 M -96 M -91.1 M -96 M -81.1 M -70.6 M -70.6 M -70.6 M -60.1 M -53 M -55.8 M -55.8 M -44.1 M -40.3 M -40.3 M -40.3 M -31 M -27.7 M -27.7 M -27.7 M -19.5 M -17.3 M -17.3 M -17.3 M -10.3 M -9.04 M -9.04 M -9.04 M -6.96 M -6.14 M -6.14 M -6.14 M -5.4 M - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-5.4 M -268 M -91.9 M

Retained Earnings of other stocks in the Biotechnology industry

Issuer Retained Earnings Price % 24h Market Cap Country
Windtree Therapeutics Windtree Therapeutics
WINT
-847 M - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
62.4 M - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
-275 M - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-475 M - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
-467 M - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
69.4 M - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
-434 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
-172 M - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-574 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
-208 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
-703 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-355 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
-968 M - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
-615 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
-917 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-228 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
-566 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
211 M - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-455 M - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-105 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-211 M $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
-260 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
-463 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
-162 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
-276 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
-418 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
-183 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
-3.31 B - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-1.25 B - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-252 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-759 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-826 M - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-562 M - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
-457 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-93.6 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
-61.7 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
-168 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-1.69 B - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-82.3 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-611 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-486 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
-71.6 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-388 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
-608 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-286 M - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
-256 M - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-301 M - -0.23 % $ 916 M usaUSA